The balloon valvuloplasty device global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Balloon Valvuloplasty Device Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The balloon valvuloplasty device market size has grown strongly in recent years. It will grow from $2.31 billion in 2023 to $2.44 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to increasing healthcare expenditure, expansion of healthcare infrastructure, improved awareness and diagnostic capabilities, preference for outpatient settings, growth of telemedicine enhancing access, and emphasis on improving quality of life for patients.
The balloon valvuloplasty device market size is expected to see strong growth in the next few years. It will grow to $3.06 billion in 2028 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to the increasing prevalence of heart valve diseases among elderly populations worldwide, increasing adoption of less invasive treatments for heart valve conditions, accelerated approvals and clearances for new balloon valvuloplasty devices, and focus on cost-effective healthcare solutions. Major trends in the forecast period include enhanced imaging modalities aiding in precise diagnosis, personalized medicine approaches, increasing research and development investments, growth of regenerative techniques in cardiovascular disease management, and integration of digital health technologies.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/balloon-valvuloplasty-device-global-market-report
Scope Of Balloon Valvuloplasty Device Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Balloon Valvuloplasty Device Market Overview
Market Drivers –
The rising inclination towards minimally invasive procedures is expected to propel the growth of the balloon valvuloplasty device market going forward. Minimally invasive procedures refer to medical techniques performed through small incisions or natural body openings, reducing trauma and promoting faster recovery compared to traditional surgeries. The demand for minimally invasive procedures is on the rise due to their reduced recovery times, lower risk of complications, and lower post-operative pain compared to traditional surgeries. Balloon valvuloplasty devices are used in minimally invasive surgical procedures to widen narrowed heart valves, improve blood flow, and reduce symptoms. For instance, in January 2024, Intuitive Surgical Inc., a US-based manufacturer of robotic products, reported that they had placed 415 da Vinci surgical systems (robotic surgical systems that use a minimally invasive surgical approach) in the fourth quarter of 2023, representing a 12% increase compared to 2022. Therefore, the rising inclination towards minimally invasive procedures is driving the growth of the balloon valvuloplasty device market.
Market Trends –
Major companies operating in the balloon valvuloplasty device market are focusing on developing advanced products, such as Pacing Guidewires, to gain a competitive edge in the market. A pacing guidewire is a specialized wire used to provide temporary cardiac pacing during the procedure, ensuring the heart maintains a stable rhythm while the balloon catheter is inserted and inflated to dilate the narrowed valve. For instance, in June 2023, Teleflex Incorporated, a US-based medical device company, received clearance from the Food and Drug Administration (FDA) for the Wattson Temporary Pacing Guidewire. This new device is designed specifically for use during transcatheter aortic valve replacement (TAVR) and balloon aortic valvuloplasty (BAV) procedures. The Wattson Temporary Pacing Guidewire offers dual functionality, supporting both valve delivery and ventricular bipolar pacing during these structural heart procedures. Its flexible distal pigtail shape, multiple electrodes, and bipolar design are engineered to help reduce the risk of ventricular perforation while providing reliable electrical capture during rapid pacing.
The balloon valvuloplasty device market covered in this report is segmented –
1) By Product Type: Standard Balloon, Cutting Balloon, Scoring Balloon, High-Pressure Balloon, Low-Pressure Balloon
2) By Age Group: Pediatric, Adult
3) By End-use: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End Uses
Get an inside scoop of the balloon valvuloplasty device market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=17090&type=smp
Regional Insights –
North America was the largest region in the balloon valvuloplasty device market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the balloon valvuloplasty device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the balloon valvuloplasty device market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Philips Healthcare, Becton Dickinson Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Biotronik SE & Co. KG, Integer Holdings Corporation, LivaNova PLC, Cordis Corporation, NuMED Inc., Pfm Medical GmbH, Tokai Medical Products Inc, Translumina GmbH, Meril Life Sciences Pvt. Ltd., Toray Medical Company Limited, QT Vascular Ltd.
Table of Contents
1. Executive Summary
2. Balloon Valvuloplasty Device Market Report Structure
3. Balloon Valvuloplasty Device Market Trends And Strategies
4. Balloon Valvuloplasty Device Market – Macro Economic Scenario
5. Global Balloon Valvuloplasty Device Market Size and Growth
.
.
.
32. Global Balloon Valvuloplasty Device Market Competitive Benchmarking
33. Global Balloon Valvuloplasty Device Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Balloon Valvuloplasty Device Market
35. Balloon Valvuloplasty Device Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
